CIK 0001655759 · Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472566120
- Phone
- 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-11 | Teel Randy President and CEO | Sale | −9,657 | $9.94 | $96K | 287,218 |
| 2026-03-18 | Berkowitz Noah Chief Medical Officer | Sale | −6,435 | $11.10 | $71K | 202,503 |
| 2026-03-06 | Morrison Briggs Director | Purchase | +20,000 | $13.40 | $268K | 96,021 |
| 2026-02-27 | Houston John G Director | Sale | −4,688 | $13.24 | $62K | 1,152,792 |
| 2026-02-27 | Houston John G Director | Sale | −18,822 | $13.24 | $249K | 1,133,970 |
| 2026-02-27 | Houston John G Director | Sale | −11,787 | $13.14 | $155K | 1,122,183 |
| 2026-02-26 | Teel Randy President and CEO | Grant or award | +147,179 | 296,875 | ||
| 2026-02-26 | Loomis David K VP, Chief Accounting Officer | Grant or award | +12,420 | 42,112 | ||
| 2026-02-26 | Loomis David K VP, Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +18,504 | 18,504 | ||
| 2026-02-26 | Cacace Angela M Chief Scientific Officer | Grant or award | +45,000 | 192,623 | ||
| 2026-02-26 | Cacace Angela M Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2026-02-26 | Berkowitz Noah Chief Medical Officer | Grant or award | +45,000 | 208,938 | ||
| 2026-02-26 | Berkowitz Noah Chief Medical Officer | Grant or award · Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2026-02-26 | Saik Andrew Chief Financial Officer | Grant or award | +45,000 | 204,267 | ||
| 2026-02-26 | Saik Andrew Chief Financial Officer | Grant or award · Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2026-02-26 | Teel Randy President and CEO | Grant or award | +147,791 | 297,487 | ||
| 2026-02-26 | Teel Randy President and CEO | Grant or award · Stock Option (right to buy) | +218,691 | 218,691 | ||
| 2026-02-23 | Loomis David K Chief Accounting Officer | Sale | −1,108 | $12.16 | $13K | 29,692 |
| 2026-02-23 | Cacace Angela M Chief Scientific Officer | Sale | −1,038 | $12.16 | $13K | 150,194 |
| 2026-02-23 | Cacace Angela M Chief Scientific Officer | Sale | −2,571 | $12.16 | $31K | 147,623 |
Page 2 of 10 · 184 trades